The recent upheavals in the United States around race relations has the nation questioning the insidious role prejudice has played in many walks of life. One group is seeking to use that rekindled awareness as added leverage to ensure equal opportunity...
Multiple hemp and dietary supplement industry trade groups have written to Reps. Kurt Schrader (D-OR) and Morgan Griffith (R-VA) to thank them for their leadership on the hemp-CBD issue.
The US Food and Drug Administration rejected mid-August a New Dietary Ingredient notification from Phoenix Biotechnology Inc for oleandrin, a constituent of oleander touted as a COVID-19 cure.
Rep. Kurt Schrader (D-OR) and Rep. Morgan Griffith (R-VA) have introduced the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 to allow hemp and hemp derived CBD to be legally marketed in dietary supplements.
Earthlight Whole Food's Vitamin D, distributed by PLT Health Solutions in the US, has received novel foods approval in the EU, allowing it to be used in 'clean label' food and beverages in Europe.
A nonprofit group has asked FDA to crack down on the sale of tianeptine, an ingredient that is sold as an antidepressant drug in many markets outside of the United States.
Products containing cannabidiol (CBD) represent a rapidly growing yet uncertain market segment, with those in the industry often finding themselves with more questions than answers.
Nascent hemp/CBD firms are often woefully unprepared for the regulatory compliance side of operating a dietary supplement firm, something an upcoming industry event aims to help fix.
Sources in the natural products industry were nearly unanimous in condemning the Trump Administration’s apparent new found enthusiasm for a toxic oleander extract as a potential COVID-19 cure.
The Federal Trade Commission has sent another round of warning letters to marketers making unsubstantiated COVID-19 health claims. The FTC’s message is simple: Prove it or remove it.
The United States’ ban of China’s popular social media application WeChat is unlikely to severely impact businesses in the dietary supplement industry, according to an industry expert.
With the UK and the European Union now on divergent paths because of Brexit, what is the state of play for regulating hemp and CBD across the pond and where are the opportunities?
The Natural Products Association said it has worked with Sen. Kevin Cramer, R-ND to introduce a bill that would allow tax-advantaged medical spending accounts to be used for certain categories of dietary supplements.
There is an urgent need to provide evidence-based nutrition education to health professionals and this pandemic may be the perfect catalyst for this change.
The Federal Trade Commission charged Golden Sunrise Nutraceutical, Inc. with deceptively advertising an ‘Emergency D-Virus’ treatment as a scientifically proven way to treat COVID-19. The company even went as far as claiming their treatment was ‘FDA accepted.’
A bill before the California State legislature would open the country’s largest market to dietary supplements and foods containing CBD, but advocates say time is running out while the machinery of state government is preoccupied with pandemic concerns.
Over 70% of Americans take dietary supplements, and by now, most consumers have probably noticed the disclaimer that says "This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.”
Scientists have set out criteria that attempts to clarify an established industry definition of probiotics, as the team addresses the term’s misuse, which contributes to confusion about probiotic health benefits.
FDA has issued a raft of warning letters over hangover cures which make the case that recovering from having had too much to drink is essentially a disease condition. In addition, some of the letters raise a potentially thorny issue concerning an ingredient...
Consumption of certain food supplements is likely to exceed safe levels of caffeine, according to a report by The Netherlands’ National Institute for Public Health and the Environment (RIVM).
The US Food and Drug Administration may be willing to sit down with a company about a possible NDI submission for full-spectrum hemp extracts, says Steve Mister, president and CEO of the Council for Responsible Nutrition (CRN).
Many recent warning letters from the Federal Trade Commission about COVID-19 are warranted, says UNPA’s Loren Israelsen, but some targeting health practitioners and what our industry has to offer in the broader immunity discussion may hint at redefining...
Essential oils purveyor Young Living has been ordered to cease making ‘therapeutic grade’ claims on its products, according to a National Advertising Division decision. The company said it plans to appeal.
An amendment to a military funding bill would make it possible for military personnel to openly use hemp/CBD products for the first time. While advocates welcome the development, there is little prospect that CBD products will become part of standard...
The USDA report that will underpin the development of the next set of Dietary Guidelines for Americans reflects a growing and welcome appreciation of the role of dietary supplements, industry observers say.
An additional seven supplement companies have been added recently to the US Food and Drug Administration’s list of firms making allegedly non compliant COVID-19 treatment claims.
The European Food and Safety Authority (EFSA) are launching a public consultation on how best to harmonise the approach for assessing the intake of nutrients contained within regulated products.
The United States Trademark Trial and Appeal Board (TTAB) recently issued a precedential decision that would control future rulings on whether a company could register a trademark for a dietary supplement or food containing cannabidiol (CBD).
The Netherlands’ Office for Risk Assessment & Research (BuRO) is advising certain populations not to consume black cohosh food supplements citing a link to severe liver toxicity.
The US Food and Drug Administration yesterday launched a website portal it calls a ‘blueprint’ for the full implementation of the Food Safety Modernization Act. The document lays out a plan for actions over the next decade.
After pausing on-site surveillance inspections in March, the Food and Drug Administration plan to resume domestic inspections starting the week of July 20.
The Center for Science in the Public Interest is urging federal authorities to require testing be done in accredited labs and not just to restrict that to the food importation process. It’s a laudable goal but one that might have unintended consequences,...
The direct selling industry has cooperated with a BBB National Programs division to issue a guidance to help companies avoid making non compliant earnings claims.
A new publication from the Botanical Adulterants Prevention Program reveals that as many as 90% of the lavender essential oil products on the market can be considered to be adulterated.
An FDA report on the CBD marketplace reveals that many of the products tested contain THC that was not identified on the labels. In addition, a majority of the products did not meet label claim for CBD content, with either too little or too much CBD.
With the UK Food Standards Agency (FSA) setting 31 March 2021 as the deadline for firms to have validated novel foods application for its CBD products, how are firms responding to this challenge especially in the current climate?
A glutathione-boosting supplement that debuted on the market recently to some fanfare has run afoul of the National Advertising Division’s COVID-19 claims monitoring program. The company, called INID Research Lab LLC, has agreed to discontinue a social...
A recent warning letter reiterates the importance of collecting adverse event reports in order to demonstrate full compliance with federal laws governing the manufacture and sale of dietary supplements.
The US Food and Drug Administration says it will move actively to prevent the worldwide trade in dietary ingredients, food ingredients and whole foods from being restricted because of misplaced coronavirus infection concerns.
UFC fighter Lyman Good claims his multi-vitamin was adulterated with an illegal steroid, causing him to fail a drug test, but according to a judge, he failed to make his case.
A contract manufacturer has received a warning letter for manufacturing products containing the stimulant DMHA, which was the subject of a concerted FDA enforcement action in 2019.
Ahead of the UK Food Standards Agency’s 31 March 2021 deadline for CBD products to have a validated novel foods application, the Association for the Cannabinoid Industry (ACI), which works to create a safe, legal and well-regulated CBD market in the UK,...
In light of the ongoing uncertainty around the COVID-19 public health crisis, the IPA World Congress + Probiota Americas 2020 has been canceled, but will return June 16-18, 2021 in Washington, D.C.
With the regulatory path forward for hemp-derived CBD in foods and supplements no clearer a year after the FDA’s May 2019 public meeting, trade association The Council for Responsible Nutrition (CRN) has filed a citizen’s petition urging the FDA to regulate...
A US Food and Drug Administration study reveals that a number of the products it tested labeled as ‘bitter orange’ did not meet label claim for synephrine content and more than 10% contained undeclared synthetic ingredients.
